Cargando…

Melanoma Cell Resistance to Vemurafenib Modifies Inter-Cellular Communication Signals

The therapeutic success of BRAF inhibitors (BRAFi) and MEK inhibitors (MEKi) in BRAF-mutant melanoma is limited by the emergence of drug resistance, and several lines of evidence suggest that changes in the tumor microenvironment can play a pivotal role in acquired resistance. The present study focu...

Descripción completa

Detalles Bibliográficos
Autores principales:	Tabolacci, Claudio, Cordella, Martina, Mariotti, Sabrina, Rossi, Stefania, Senatore, Cinzia, Lintas, Carla, Levati, Lauretta, D’Arcangelo, Daniela, Facchiano, Antonio, D’Atri, Stefania, Nisini, Roberto, Facchiano, Francesco
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2021
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7830125/ https://www.ncbi.nlm.nih.gov/pubmed/33467521 http://dx.doi.org/10.3390/biomedicines9010079

Ejemplares similares

Identification of Dihydrolipoamide Dehydrogenase as Potential Target of Vemurafenib-Resistant Melanoma Cells
por: Tabolacci, Claudio, et al.
Publicado: (2022)

TNF-alpha and metalloproteases as key players in melanoma cells aggressiveness
por: Rossi, Stefania, et al.
Publicado: (2018)

PDGFR-alpha inhibits melanoma growth via CXCL10/IP-10: a multi-omics approach
por: D'Arcangelo, Daniela, et al.
Publicado: (2016)

Nicotinamide inhibits melanoma in vitro and in vivo
por: Scatozza, Francesca, et al.
Publicado: (2020)

Differential Denaturation of Serum Proteome Reveals a Significant Amount of Hidden Information in Complex Mixtures of Proteins
por: Verdoliva, Vincenzo, et al.
Publicado: (2013)

Targeting Melanoma-Initiating Cells by Caffeine: In Silico and In Vitro Approaches
por: Tabolacci, Claudio, et al.
Publicado: (2021)

Beneficial Role of Phytochemicals on Oxidative Stress and Age-Related Diseases
por: Forni, Cinzia, et al.
Publicado: (2019)

Investigating Serum and Tissue Expression Identified a Cytokine/Chemokine Signature as a Highly Effective Melanoma Marker
por: Cesati, Marco, et al.
Publicado: (2020)

Identification of Serum Regression Signs in Infantile Hemangioma
por: D'Arcangelo, Daniela, et al.
Publicado: (2014)

Neuropilin-1 expressing melanoma cells as a model to study the aggressiveness of metastatic melanoma
por: Ruffini, Federica, et al.
Publicado: (2015)

WIPI1, BAG1, and PEX3 Autophagy-Related Genes Are Relevant Melanoma Markers
por: D'Arcangelo, Daniela, et al.
Publicado: (2018)

Ion Channel Expression in Human Melanoma Samples: In Silico Identification and Experimental Validation of Molecular Targets
por: D’Arcangelo, Daniela, et al.
Publicado: (2019)

Lipid Storage and Autophagy in Melanoma Cancer Cells
por: Giampietri, Claudia, et al.
Publicado: (2017)

Platelet-derived growth factor-C promotes human melanoma aggressiveness through activation of neuropilin-1
por: Ruffini, Federica, et al.
Publicado: (2017)

Role of VEGFR‐1 in melanoma acquired resistance to the BRAF inhibitor vemurafenib
por: Atzori, Maria Grazia, et al.
Publicado: (2019)

Phytochemicals as Immunomodulatory Agents in Melanoma
por: Tabolacci, Claudio, et al.
Publicado: (2023)

Deletion of a Single Lysine Residue at Position 292 of CAMK2A Disrupts Protein Function, Causing Severe Epileptic Encephalopathy and Intellectual Disability
por: Lintas, Carla, et al.
Publicado: (2023)

RAM, an RGDS Analog, Exerts Potent Anti-Melanoma Effects In Vitro and In Vivo
por: Aguzzi, Maria Simona, et al.
Publicado: (2011)

Letter to the Editor: “Ion Channels in Brain Metastasis”—Ion Channels in Cancer Set up and Metastatic Progression
por: D’Arcangelo, Daniela, et al.
Publicado: (2017)

Targeting the PTTG1 oncogene impairs proliferation and invasiveness of melanoma cells sensitive or with acquired resistance to the BRAF inhibitor dabrafenib
por: Caporali, Simona, et al.
Publicado: (2017)

Resveratrol Counteracts Inflammation in Human M1 and M2 Macrophages upon Challenge with 7-Oxo-Cholesterol: Potential Therapeutic Implications in Atherosclerosis
por: Buttari, Brigitta, et al.
Publicado: (2014)

Natural Compounds against Cancer, Inflammation, and Oxidative Stress
por: Tabolacci, Claudio, et al.
Publicado: (2019)

Ion channels expression and function are strongly modified in solid tumors and vascular malformations
por: Biasiotta, Antonella, et al.
Publicado: (2016)

NF-κB is activated in response to temozolomide in an AKT-dependent manner and confers protection against the growth suppressive effect of the drug
por: Caporali, Simona, et al.
Publicado: (2012)

Melanoma cells with acquired resistance to dabrafenib display changes in miRNA expression pattern and respond to this drug with an increase of invasiveness, which is abrogated by inhibition of NF-κB or the PI3K/mTOR signalling pathway
por: Caporali, Simona, et al.
Publicado: (2015)

Vitiligo-specific soluble biomarkers as early indicators of response to immune checkpoint inhibitors in metastatic melanoma patients
por: Carbone, Maria Luigia, et al.
Publicado: (2022)

miR-126-3p down-regulation contributes to dabrafenib acquired resistance in melanoma by up-regulating ADAM9 and VEGF-A
por: Caporali, Simona, et al.
Publicado: (2019)

BRAF Mutations in Melanoma: Biological Aspects, Therapeutic Implications, and Circulating Biomarkers
por: Castellani, Giorgia, et al.
Publicado: (2023)

Melanoma and Vitiligo: In Good Company
por: Failla, Cristina Maria, et al.
Publicado: (2019)

Expression of Autoimmunity-Related Genes in Melanoma
por: Scatozza, Francesca, et al.
Publicado: (2022)

Circulating miR-1246 and miR-485-3p as Promising Biomarkers of Clinical Response and Outcome in Melanoma Patients Treated with Targeted Therapy
por: Levati, Lauretta, et al.
Publicado: (2022)

Concomitant BCORL1 and BRAF Mutations in Vemurafenib-Resistant Melanoma Cells()
por: Mologni, Luca, et al.
Publicado: (2018)

Intra- and inter-tumor heterogeneity in a vemurafenib-resistant melanoma patient and derived xenografts
por: Kemper, Kristel, et al.
Publicado: (2015)

Editorial: Artificial Intelligence Bioinformatics: Development and Application of Tools for Omics and Inter-Omics Studies
por: Chicco, Davide, et al.
Publicado: (2020)

An investigation into the molecular basis of cancer comorbidities in coronavirus infection
por: Facchiano, Antonio, et al.
Publicado: (2020)

Combined vemurafenib and fotemustine in patients with BRAF V600 melanoma progressing on vemurafenib
por: Queirolo, Paola, et al.
Publicado: (2016)

Metastatic melanoma and vemurafenib: novel approaches
por: De Mello, Ramon Andrade
Publicado: (2012)

A STATement on Vemurafenib-Resistant Melanoma
por: Hartsough, Edward J., et al.
Publicado: (2013)

The Tubulin Inhibitor VERU-111 in Combination With Vemurafenib Provides an Effective Treatment of Vemurafenib-Resistant A375 Melanoma
por: Cui, Hongmei, et al.
Publicado: (2021)

Editorial on Special Issue “Advances and Novel Treatment Options in Metastatic Melanoma”
por: Carè, Alessandra, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_fkrccta0ju7itjk5ra1fcctokr